Description
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte stimulating hormone (α-MSH), developed for laboratory investigation of melanocortin receptor-mediated signalling pathways. It is studied in in-vitro and preclinical settings for its interactions with melanocortin receptor subtypes (MC1R, MC3R, MC4R), intracellular cAMP signalling cascades, and downstream transcriptional regulatory mechanisms. This product is supplied as a lyophilised research-grade compound at a nominal mass of 10mg per unit.
Catalogue information
• Synonym: Bremelanotide
• CAS: 189691-06-3
• Molecular formula: C₅₀H₆₈N₁₄O₁₀
• Molecular weight: ~1025.18 g/mol
• Peptide length: 7 amino acids (cyclic)
• Form: Lyophilised powder
• Purity: ≥99% (HPLC verified)
• Appearance: White to off-white powder
• Storage: −20°C, desiccated, protected from light
• Reconstitution: For laboratory use only — refer to in-house research protocols
Certificate of Analysis available on request.
This product is supplied strictly for laboratory and in-vitro research purposes only. Not intended for human or veterinary use. For research use only (RUO). Handling should be carried out by qualified research personnel in accordance with applicable laboratory safety guidelines. This compound is not licensed for clinical or therapeutic use in the United Kingdom.
For licensed laboratory and in vitro research use only. Not for human consumption. Not a medicinal product.
Reviews
There are no reviews yet.